Prevalence of Amyloidosis in Trauma Patients
Recruiting
- Conditions
- Amyloidosis
- Registration Number
- NCT06527521
- Lead Sponsor
- Consorci Sanitari de l'Alt Penedès i Garraf
- Brief Summary
This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 246
Inclusion Criteria
- Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness > 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP > 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
- Ability to cooperate in the necessary evaluations.
- Signed informed consent for inclusion in the study, either by the participant or their legal representative.
Exclusion Criteria
- Participants previously diagnosed with amyloidosis cannot be included in the study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amyloidosis One month Proportion of patients undergoing scheduled orthopedic surgery who are diagnosed with amyloidosis.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil
🇪🇸Sant Pere De Ribes, Barcelona, Spain